Table 3.

Spearman correlation coefficients of SPARCC score with disease activity, QOL, and WPAI measures.

VariablesNSpearman Correlation CoefficientP
CDAI18520.272< 0.001
HAQ-DI18550.237< 0.001
DAPSA10000.391< 0.001
Modified MDA (total score)a1659−0.311< 0.001
Patient-reported pain18430.230< 0.001
Patient-reported fatigue19620.201< 0.001
Patient global assessment19610.117< 0.001
WPAI
% Work time missed9790.135< 0.001
% Impairment while working10360.191< 0.001
% Overall work impairment9140.206< 0.001
% Activity impairment17350.253< 0.001
  • aThis variable is the total score of the 6 criteria for modified MDA: tender joint count ≤ 1, swollen joint count ≤ 1, BSA ≤ 3%, patient pain VAS ≤ 15, patient global assessment VAS ≤ 20, and HAQ-DI ≤ 0.5. BSA: body surface area; CDAI: Clinical Disease Activity Index; DAPSA: Disease Activity Index for Psoriatic Arthritis; HAQ-DI: Health Assessment Questionnaire–Disability Index; MDA: minimal disease activity (defined as meeting ≥ 5 of the following criteria: tender joint count ≤ 1, swollen joint count ≤ 1, BSA ≤ 3%, patient pain VAS ≤ 15, patient global assessment VAS ≤ 20, and HAQ-DI ≤ 0.5); QOL: quality of life; SPARCC: Spondyloarthritis Research Consortium of Canada; VAS: visual analog scale; WPAI: Work Productivity and Activity Impairment.